Akero Therapeutics

The Director will serve as a Medical Monitor for Phase 3 clinical trials, overseeing safety data and ensuring successful trial execution. They will also contribute to regulatory submissions, scientific disclosures, and provide medical expertise to internal and external stakeholders.